Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice

Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we inves...

Source: Cardiovascular Diabetology - July 26, 2018 Category: Cardiology Authors: Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva and Eva Kassi Tags: Original investigation Source Type: research